Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet

British Journal of Nutrition

Volumn 108, Issue 8, 2012, Pages 1466-1474

  Munro, Irene A ^a   Garg, Manohar L ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Long chain n 3 PUFA; Very low energy diets; Weight loss; Weight maintenance

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY FAT; BODY MASS; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; LOW CALORY DIET; MALE; NORMAL HUMAN; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; CALORIC RESTRICTION; DIET, REDUCING; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 84865643238     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006817     Document Type: Article

References (60)

1. Fruhbeck G (2007) Vasoactive factors and inflammatory mediators produced in adipose tissue. In Adipose Tissue and Adipokines in Health and Disease, pp. 63-77 [G Fantuzzi and T Mazzone, editors]. Totowa: Human Press, Inc.
2. NCEP (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
3. Weisberg SP, McCann D, Desai M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
4. Blake GJ & Ridker PM (2001) High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 22, 349-352.
5. Lau DC, Dhillon B, Yan H, et al. (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288, H2031-H2041.
6. Blake GJ & Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89, 763-771.
7. Nesto RW (2005) Obesity: a major component of the metabolic syndrome. Tex Heart Inst J 32, 387-389.
8. Jellema A, Plat J&Mensink RP (2004)Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34, 766-773.
9. Krebs JD, Browning LM, McLean NK, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 1535-1544.
10. Williamson DF (1997) Intentional weight loss: patterns in the general population and its association with morbidity and mortality. Int J Obes Relat Metab Disord 21, Suppl. 1, S14-S19, discussion S20-S11.
11. Calder PC (2002) Dietary modification of inflammation with lipids. Proc Nutr Soc 61, 345-358.
12. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30, 785-807.
13. Belalcazar LM, Reboussin DM, Haffner SM, et al. (2010) Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33, 197-199.
14. Gunnarsdottir I, Tomasson H, Kiely M, et al. (2008) Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids. Int J Obes (Lond) 32, 1105-1112.
15. Harris WS (1996) n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31, 243-252.
16. Nakatani T, Kim HJ, Kaburagi Y, et al. (2003) A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J Lipid Res 44, 369-379.
17. Ruzickova J, Rossmeisl M, Prazak T, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 1177-1185.
18. Buckley JD & Howe PR (2009) Anti-obesity effects of longchain omega-3 polyunsaturated fatty acids. Obes Rev 10, 648-659.
19. Blackburn G (1995) Effect of degree of weight loss on health benefits. Obes Res 3, Suppl. 2, 211s-216s.
20. Klein S (2001) Outcome success in obesity. Obes Res 9, Suppl. 4, 354S-358S.
21. Kellet E, Smith AE & Schmerlaib Y (1998) The Australian Guide to Healthy Eating. Canberra: Australian Government Department of Health and Ageing.
22. Lepage G & Roy CC (1986) Direct transesterification of all classes of lipids in a one step reaction. J Lipid Res 27, 114-120.
23. Rothacker DQ & Watemberg S (2004) Short-term hunger intensity changes following ingestion of a meal replacement bar for weight control. Int J Food Sci Nutr 55, 223-226.
24. Raclot T, Groscolas R, Langin D, et al. (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38, 1963-1972.
25. Minami A, Ishimura N, Sakamoto S, et al. (2002) Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Br J Nutr 87, 157-162.
26. Kunesova M, Braunerova R, Hlavaty P, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55, 63-72.
27. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31, 1560-1566.
28. DeFina LF, Marcoux LG, Devers SM, et al. (2011) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 93, 455-462.
29. Couet C, Delarue J, Ritz P, et al. (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 21, 637-643.
30. Kabir M, Skurnik G, Naour N, et al. (2007) Treatment for 2mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86, 1670-1679.
31. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. (2007) N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97, 823-831.
32. Klein-Platat C, Drai J, Oujaa M, et al. (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178-1184.
33. Karlsson M, Marild S, Brandberg J, et al. (2006) Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity (Silver Spring) 14, 1931-1939.
34. Micallef M, Munro I, Phang M, et al. (2009) Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102, 1370-1374.
35. Astrup A & Rossner S (2000) Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev 1, 17-19.
36. McGuire MT, Wing RR, Klem ML, et al. (1999) What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol 67, 177-185.
37. Anderson JW, Konz EC, Frederich RC, et al. (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74, 579-584.
38. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 19L-22L.
39. Poobalan A, Aucott L, Smith WC, et al. (2004) Effects of weight loss in overweight/obese individuals and long-term lipid outcomes-a systematic review. Obes Rev 5, 43-50.
40. Dattilo AM & Kris-Etherton PM (1992) Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56, 320-328.
41. Ditschuneit HH, Flechtner-Mors M, Johnson TD, et al. (1999) Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 69, 198-204.
42. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30.
43. Micallef MA & Garg ML (2008) The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr 138, 1086-1090.
44. Micallef MA & Garg ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476-482.
45. Connor WE (1968) Dietry sterols: their relationship to atherosclerosis. J Am Diet Assoc 52, 202-208.
46. Harris WS & Bulchandani D (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17, 387-393.
47. Anubhuti & Arora S (2008) Leptin and its metabolic interactions: an update. Diabetes Obes Metab 10, 973-993.
48. Boden G, Chen X, Mozzoli M, et al. (1996) Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81, 3419-3423.
49. Maffei M, Halaas J, Ravussin E, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155-1161.
50. Kolaczynski JW, Considine RV, Ohannesian J, et al. (1996) Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45, 1511-1515.
51. Mori TA, Burke V, Puddey IB, et al. (2004) Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 22, 1983-1990.
52. Puglisi MJ, Hasty AH & Saraswathi V (2011) The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem 22, 101-108.
53. Selvin E, Paynter NP & Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31-39.
54. Tsitouras PD, Gucciardo F, Salbe AD, et al. (2008) High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40, 199-205.
55. Madsen T, Christensen JH, Blom M, et al. (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89, 517-522.
56. Puglisi MJ & Fernandez ML (2008) Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 138, 2293-2296.
57. Caughey GE, Mantzioris E, Gibson RA, et al. (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116-122.
58. Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93, 243-252.
59. Madsen EL, Rissanen A, Bruun JM, et al. (2008) Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158, 179-187.
60. Attie AD, Krauss RM, Gray-Keller MP, et al. (2002) Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43, 1899-1907.